MedPath

A comparison of concurrent chemo-radiotherapy plus hyperthermia versus concurrent chemo-radiotherapy in locally advanced cervical cancer patients: A randomized controlled trial

Phase 3
Conditions
&#45
This study aim to compare concurrent chemoradiotherapy and concurrent chemoradiotherapy plus hyperthermia in locally advanced cervical cancer in term of treatment response rate.
radiation therapy
chemotherapy
Deep regional hyperthermia
Thermotron&#45
RF8
Registration Number
TCTR20180711002
Lead Sponsor
Chulabhorn Hospital, HRH Princess Chulabhorn College of Medical Science, Chulabhorn Royal Academy
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
nknown
Sex
Female
Target Recruitment
90
Inclusion Criteria

- CA cervix FIGO stage IB2, IIA2-IVA
- Patho : squamous cell carcinoma, adenosquamous carcinoma or adenocarcinoma
- Age more than 18 years
- KPS > 70
- Treatment plan is concurrent chemoradiotherapy
- No paraaortic lymph node metastasis
- Adequate bone marrow and kidney function
- No HIV history

Exclusion Criteria

- Patients have cardiac pacemaker or metal prosthesis in their body
- Patients received abdominal radiotherapy or chemotherapy
- Distant metastases
- Previous malignancy, except adequately treated non-melanoma skin cancer

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath